High Throughput Screening Market Size Worth $30.91 Billion by 2025: Grand View Research, Inc.
SAN FRANCISCO, May 16, 2018 /PRNewswire/ --
The global high throughput screening market size is expected to generate a revenue of USD 30.91 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 7.89% during the forecast period. Increasing adoption of faster and accurate technology by pharmaceutical companies to introduce newer molecules in the market is anticipated to provide a significant push to the market.
(Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg )
High throughput screening is used for testing of molecules in development phase on various grounds such as chemical, pharmaceutical, and genetic reactions. These screenings help in drug design and development based on real time results and near natural conditions that mimic natural reactions between the molecule and the body.
Moreover, this method can be fully automated using required hardware and software capable of handling a fully automated process along with data storage units that store and process considerable amount of data in short span of time.
As of 2016, approximately 55.0% of high throughput screening tests are carried out based on the cell based assays. Cell based assays are used majorly owing to the results that can be obtained at cellular levels along with pathways and mechanism.
These assays range from cytotoxic tests, including apoptosis, to cell metabolic assays. One more major technology implantation is the introduction of 3D - cell culture, which can help mimic natural conditions that give more accurate results and reactions to tests carried on. This trend is estimated to support the growth of the market during the forecast period.
Browse full research report with TOC on "High Throughput Screening (HTS) Market Size, Share & Trends Analysis Report By Application (Drug Discovery, Cell- and Organ-based Screening, Biochemical Screening), By Technology, And Segment Forecasts, 2018 - 2025" at: https://www.grandviewresearch.com/industry-analysis/high-throughput-screening-market
Further Key Findings From the Report Suggest:
- The market is driven by increasing competition between pharmaceutical companies to introduce novel molecules
- Emerging 3D cell culture technology that provides better results in real time is set to boost the market
- North America emerged as the clear hotspot for the development and adoption of this technology and had a major share in the market
- Emerging regions such as Asia Pacific and Latin America are set to witness considerable growth in demand over the forecast period driven by the need of newer molecules to cure various diseases
- Some of the key players in this market are Agilent Technologies, Inc., Danaher Corporation, Thermofisher Scientific, Inc., PerkinElmer, Inc. and Tecan Group Ltd., Merck Millipore, Bio-Rad laboratories, Hamilton Company, Axxam S.p.A., and Aurora Biomed.
Browse related reports by Grand View Research:
- Multi-Infarct Dementia Market - Rising prevalence of strokes and blockage in brain nerves is expected to be major factor driving the global multi infarct dementia market.
- Live Cell Imaging Market - The global live cell imaging market size was valued at USD 4.3 billion in 2016 and is projected to grow with CAGR of 8.5% over the forecast period.
- Glycomics/ Glycobiology Market - The global glycomics/ glycobiology market size was estimated at USD 645.7 million in 2016.
- Protein Engineering Market - The global protein engineering market size was valued at 823.0 million in 2016
Grand View Research has segmented the global high throughput screening market by technology, application, and region:
- High Throughput Screening Technology Outlook (Revenue, USD Billion, 2014 - 2025)
- Cell-based Assays
- Fluorometric Imaging Plate Reader Assays
- Clinical applications (Cardiotoxicity assays)
- In-vitro studies (Pharmacophores identification in drug discovery)
- Reporter based Assays
- Clinical applications (Reporter assay in biological systems analysis)
- In-vitro studies (Genetic reporter assays in cloning tools for live-cell work)
- Fluorometric Imaging Plate Reader Assays
- 3D - Cell Cultures
- Clinical applications (Regenerative medicine)
- In-vitro studies (Drug discovery, Molecular cell biology)
- Ultra High Throughput Screening
- Cell-based Assays
- High Throughput Screening Application Outlook (Revenue, USD Billion, 2014 - 2025)
- Drug discovery programs
- Chemical biology programs
- Biochemical screening
- Cell- & organ-based screening
- High Throughput Screening Regional Outlook (Revenue, USD Billion, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K
- Asia Pacific
- China
- Japan
- Latin America
- Brazil
- MEA
- South Africa
- North America
Explore the BI enabled intuitive market research database, The Grand Library, by Grand View Research, Inc.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Share this article